CDKN2B-AS1 and pancreatic neoplasm: In addition, Wang et al. [21] showed that SRSF3 enhances pancreatic cancer resistance to gemcitabine by controlling ANRIL splicing and its association with m6A methylation levels in the lncRNA ANRIL.